ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

3.83
Delayed Data
As of Feb 16
 -0.05 / -1.29%
Today’s Change
3.33
Today|||52-Week Range
7.88
-7.49%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close3.88
Today’s open3.87
Day’s range3.80 - 3.95
Volume1,248,886
Average volume (3 months)1,885,765
Market cap$543.7M
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+59.39%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-0.10-0.42%
BYSIBeyondspring Inc+0.38+1.45%
ATNXAthenex Inc-0.11-0.66%
ACORAcorda Therapeutics ...+0.70+2.79%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Laurence James Neil Cooper
Executive VP, Chief Operating &
Business Officer
David M. Mauney
Corporate headquarters
Boston, Massachusetts

Forecasts